Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 38 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 10786512

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  2. US 10787452

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  3. US 10781218

    Substituted inhibitors of menin-MLL and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted
  4. US 10781183

    Small molecule inducers of reactive oxygen species and inhibitors of mitochondrial activity

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted
  5. US 10781181

    N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors

    KalVista Pharmaceuticals Limited · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted
  6. US 10781208

    5,6-dihydro-11H-indolo[2,3-B]quinolin-11-ones as alk inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted
  7. US 10774092

    ULK1 inhibitors and methods using same

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  8. US 10774080

    Pyrimidine compound as JAK kinase inhibitor

    Theravance Biopharma R&D IP, LLC · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  9. US 10774056

    Substituted piperazines as selective HDAC1,2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  10. US 10772861

    Administration of serine protease inhibitors to the stomach

    The Regents of the University of California · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  11. US 10766892

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  12. US 10765694

    Compositions and methods for delivering inhibitory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  13. US 10766903

    Piperidine derivatives as inhibitors of ubiquitin specific protease 7

    ALMAC DISCOVERY LIMITED · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  14. US 10759759

    Prodrugs of kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  15. US 10759791

    Mammalian and bacterial nitric oxide synthase inhibitors

    Northwestern University · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  16. US 10759796

    CXCR4 inhibitors and uses thereof

    X4 Pharmaceuticals, Inc. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  17. US 10759813

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  18. US 10759793

    2-(pyrazolopyridin-3-yl)pyrimidine derivatives as JAK inhibitors

    Almirall, S.A. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  19. US 10759774

    Inhibitors of hepatitis B virus targeting capsid assembly

    Regents of the University of Minnesota · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  20. US 10758511

    Stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  21. US 10759816

    Heterocyclic compounds as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  22. US 10758530

    Carboxamide derivatives useful as rsk inhibitors

    PHOENIX MOLECULAR DESIGNS · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  23. US 10752598

    Aryldiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  24. US 10752639

    Bridged bicyclic inhibitors of menin-MLL and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted